DENVER- Arsenic is a natural element in the environment, sometimes found in air, soil and water. Arsenic contaminated water is a global threat, currently affecting more than 100 million people. Both genetic and epigenetic changes drive arsenic-induced carcinogenesis and lung cancer is one of the main consequences of this process.
Researchers from the British Columbia Cancer Research Center have analyzed a panel of lung tumors from a population exposed to arsenic. Victor Martinez, researcher at the British Columba Cancer Research Center, will share his latest research at the 5th Latin American Conference on Lung Cancer.
"Lung tumors induced by arsenic are different molecular entities and specific therapeutic approaches should be considered," Martinez says. "These results may help to prevent arsenic-related cancer in other parts of the world, such as USA and Canada, where exposure to arsenic (even at low levels) has been also linked with lung cancer and other diseases."
Martinez will share the latest on his research at an abstract session Thursday, July 26 at 8 a.m. in the Louvre I room at the Windsor Barra Hotel.
He is willing to do media interviews. The media is invited to attend all events with proper registration. All events will be simultaneously translated from English to Portuguese. To register, please visit the Media and Press page on the Conference website at www.lalca2012.org/media_press.
The 5th Latin American Conference on Lung Cancer will highlight the latest in lung cancer research and tobacco control. Nearly 1,000 medical professionals will gather at the conference to discuss the latest lung cancer research and treatment. Lung cancer kills more than 1.5 million people each year worldwide. It is also among the most challenging cancers to treat. Yet, there is excitement and hope, thanks to new advances which are improving the chances of better outcomes.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 3,500 lung cancer specialists in 80 countries. To learn more about IASLC please visit www.iaslc.org.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.